*Masaki Okubo¹, Hiroshi Doi¹, Shunta Hashiguchi¹, Misako Kunii¹, Keita Takahashi¹, Mikiko Tada¹, Kenichi Tanaka¹, Hideyuki Takeuchi¹, Taro Ishikawa², Fumiaki Tanaka¹ (1. Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 2. Department of Pharmacology, The Jikei University School of Medicine)

*Youichi Shinozaki^1,2, Alex Leung³, Kazuhiko Namekata⁴, Nobuhiko Ohno^5,6, Eiji Shigetomi^2,1, Kenji Kashiwagi⁷, Takayuki Harada⁴, Shin-Ichi Ohnuma³, Schuichi Koizumi^1,2 (1. Dept Neuropharmacol, Grad Sch Med, Univ Yamanashi, Yamanashi, Japan, 2. GLIA Cent, Grad Sch Med, Univ Yamanashi, Yamanashi, Japan, 3. UCL Inst Ophthalmol, UCL, London, UK, 4. Vis Res Project, Tokyo Metr Inst Med, Tokyo, Japan, 5. Div Ultrastract Res, Natl Inst Physiol Sci, Aichi, Japan, 6. Div Anatomy, Jichi Med Univ, Tochigi, Japan, 7. Dept Ophthalmol, Interdisp Grad Sch Med, Univ Yamanashi, Yamanashi, Japan)

*Seiji Watanabe¹, Kotaro Oiwa^1,2, Koji Yamanaka¹ (1. RIEM, Nagoya Univ, Aichi, Japan, 2. Grad Sch Med, Nagoya Univ, Aichi, Japan)

*Fumio Takahashi^1,3, Chenyang Zhang¹, Hirohiko Hohjoh², Ben Raveney¹, Takashi Yamamura¹, Nobuhiro Hayashi³, Shinji Oki¹ (1. Dept. of Immunol., Natl Inst Neurol. NCNP, 2. Dept. of Mol Pharmacol., Natl Inst Neurol. NCNP, 3. Grad. Sch. of Life Sci and Technol., Titech)